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OBJECTIVES: The timely initiation of insulin therapy in
patients with type-2 diabetes who fail to achieve good
control on oral antidiabetic therapy is pivotal to success-
ful health outcomes in diabetes. Yet, signiﬁcant barriers
exist to patient acceptance of insulin therapy and to ade-
quate self-management of insulin regimens once initiated.
The disposable insulin device, InnoLet, is designed to
meet the needs of elderly patients. This study set out 
to evaluate the differences in psychological fear of self-
injecting insulin and perception of barriers to compliance
with the insulin regimen in patients using the InnoLet pre-
ﬁlled device and the vial and syringe. METHODS: Eighty
diabetes patients >60 years of age and having visual and
or motor disabilities were enrolled in this two-period
crossover study, which had as primary aim to evaluate
resource utilisation and patient preference. Subjects had
difﬁculty or required caregiver assistance for their previ-
ous regimen of injections by vial/syringe. Subjects were
randomised to use of either vial and syringe or InnoLet
for 6 weeks, and then assigned the opposite treatment for
six weeks. At baseline and at the end of each period, 
subjects completed the Diabetes Fear of Self-injection
Questionnaire (D-FISQ) and questions about barriers to
insulin self-care, treatment satisfaction and preference.
RESULTS: The D-FISQ showed good internal consis-
tency. Compared to baseline values, InnoLet treatment
resulted in an improvement of 39% and 67% respectively
in each of the 2 groups in fear of self-injection, whereas
vial-syringe treatment resulted in small improvements 
of 4,7% and 17% respectively from baseline. Detailed
statistical analyses of the relationships between injection
fear, treatment barriers and health care utilisation further
demonstrate the clinical importance of injection fear.
CONCLUSION: The preﬁlled InnoLet device offers
important psychological beneﬁts to elderly insulin depen-
dent diabetes patients with visual and or motor dis-
abilities. The clinical signiﬁcance of these ﬁndings is
substantial, given the signiﬁcant health gains that can be
obtained with effective insulin therapy.
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OBJECTIVES: Proﬁle measures of health-related quality
of life (HRQoL) are not adequate for all purposes in
health economics, but when the effects of a disease or
medical treatment to some speciﬁc domain of health are
considered, proﬁle measures can provide results that are
illustrative and easy to interpret. In this study we examine
how the effects of type 1 diabetes (TID) and the symp-
toms of its chronic long-term complications affect the
hypothesized physical and mental domains of HRQoL.
METHODS: A representative sample of patients with
TID was selected randomly from the Finnish drug reim-
bursement registry. Patients then reported symptoms,
diagnoses, and treatments indicating time of appearance
and presence of long-term complications, and ﬁlled
RAND-36 questionnaire. An explorative factor analysis
was performed to test the hypothesis of 2-factor model
of health. The results were validated with split-sample
analysis. Regression analyses were used in estimating the
effects of age, gender and symptoms of long-term com-
plications to the factor component T-scores. RESULTS:
Of the 752 (70.8%) patients who responded, 592 were
with TID and 96.2% completed the RAND-36 question-
naire. Factor analysis of our data supports the theory of
the 2-factor model of health; physical and mental health
components were reﬂected unambiguously by different
RAND-36 dimensions. The regression results show that
the symptoms of long-term complications inﬂuence much
stronger on physical than mental domain of the HRQoL.
The number of signiﬁcant symptoms was higher in phys-
ical component model (5/8 vs. 3/8) and the coefﬁcient
values of those were higher (3.1–4.4 vs. 2.3–3.7). CON-
CLUSIONS: TID and especially the symptoms of its long-
term complications affect mainly the physical domain of
health, although the mental domain is also affected. The
prevalence of long-term complications of TID in different
age groups is sufﬁciently high to substantially inﬂuence
on the quality of life of the patients.
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OBJECTIVE: To determine the accuracy of self-reported
glucose levels among people with diabetes. METHODS:
In August 1999, 903 people with diabetes were sent an
at-home HbA1c test kit and a brief questionnaire about
blood glucose monitoring and diabetes management. The
sample was obtained through an on-going, longitudinal
diabetes study. A total of 450 respondents provided a self-
reported range of blood glucose levels and completed the
home test kit. The midpoint and highest glucose level
were compared to laboratory HbA1c values using a
regression equation calculated from a previously pub-
lished formula. The percentage of respondents misesti-
mating their diabetes control was determined. RESULTS:
